- Home
- VIR vs DAVA Comparison
VIR vs DAVA Comparison
Compare VIR & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- DAVA
- Stock Information
- Founded
- VIR 2016
- DAVA 2000
- Country
- VIR United States
- DAVA United Kingdom
- Employees
- VIR N/A
- DAVA N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- DAVA EDP Services
- Sector
- VIR Health Care
- DAVA Technology
- Exchange
- VIR Nasdaq
- DAVA Nasdaq
- Market Cap
- VIR 706.4M
- DAVA 761.0M
- IPO Year
- VIR 2019
- DAVA 2018
- Fundamental
- Price
- VIR $4.38
- DAVA $12.99
- Analyst Decision
- VIR Strong Buy
- DAVA Buy
- Analyst Count
- VIR 8
- DAVA 9
- Target Price
- VIR $30.25
- DAVA $25.22
- AVG Volume (30 Days)
- VIR 1.0M
- DAVA 732.0K
- Earning Date
- VIR 08-06-2025
- DAVA 09-18-2025
- Dividend Yield
- VIR N/A
- DAVA N/A
- EPS Growth
- VIR N/A
- DAVA N/A
- EPS
- VIR N/A
- DAVA 0.40
- Revenue
- VIR $19,000,000.00
- DAVA $1,007,631,882.00
- Revenue This Year
- VIR N/A
- DAVA $6.32
- Revenue Next Year
- VIR $0.56
- DAVA N/A
- P/E Ratio
- VIR N/A
- DAVA $31.95
- Revenue Growth
- VIR N/A
- DAVA 5.95
- 52 Week Low
- VIR $4.16
- DAVA $11.63
- 52 Week High
- VIR $14.45
- DAVA $34.94
- Technical
- Relative Strength Index (RSI)
- VIR 35.16
- DAVA 47.33
- Support Level
- VIR $4.33
- DAVA $12.44
- Resistance Level
- VIR $4.57
- DAVA $13.13
- Average True Range (ATR)
- VIR 0.22
- DAVA 0.61
- MACD
- VIR -0.02
- DAVA 0.11
- Stochastic Oscillator
- VIR 21.53
- DAVA 51.72
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.